✦ LIBER ✦

866 Second-line treatment of advanced urothelial cancer – safety of combinatory treatment with paclitaxel and RAD001 (everolimus) in a German phase II trial (AUO trial AB 35/09)

✍ Scribed by G. Niegisch; M. Retz; A. Hartmann; M. Thalgott; J. Gschwend; Dorp F. Vom; M. Stöckle; C. Ohlmann; M. Bögemann; S. Balabanov; C. Ohmann; P. Albers

Book ID: 119624797
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 17 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(12)60863-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II trial of gemcitabine

Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99)

✍ G. Fechner; R. Siener; M. Reimann; L. Kobalz; P. Albers; Members Of The German A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Topotecan and paclitaxel in second line

Topotecan and paclitaxel in second line treatment of advanced ovarian cancer (AOC): a gineco phase II trial

✍ Fabbro, M.; Leduc, B.; Mignot, L.; Ayela, P.; Assouline, D.; Gouttebel, M.C.; Le 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Activity and safety of erlotinib as seco

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

✍ David Rossi; Donatella Dennetta; Marcello Ugolini; Vincenzo Catalano; Paolo Ales 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 129 KB

Phase I/II trial of oral UFT/Leucovorin

Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)

✍ Klaassen, U.; Lang, S.; Borquez, D.; Oberhoff, C.; Benner, S.; Harstrick, A.; Se 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 322 KB

A phase II study of weekly carboplatin a

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer: A Multicentre Italian Trial in Ovarian cancer (MITO-5) study

✍ Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 208 KB

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB